Sleep architecture and the risk of incident dementia in the community
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: Sleep disturbance is common in dementia, although it is unclear whether differences in sleep architecture precede dementia onset. We examined the associations between sleep architecture and the prospective risk of incident dementia in the community-based Framingham Heart Study (FHS).
Methods: Our sample comprised a subset of 321 FHS Offspring participants who participated in the Sleep Heart Health Study between 1995 and 1998 and who were aged over 60 years at the time of sleep assessment (mean age 67 ± 5 years, 50% male). Stages of sleep were quantified using home-based polysomnography. Participants were followed for a maximum of 19 years for incident dementia (mean follow-up 12 ± 5 years).
Results: We observed 32 cases of incident dementia; 24 were consistent with Alzheimer disease dementia. After adjustments for age and sex, lower REM sleep percentage and longer REM sleep latency were both associated with a higher risk of incident dementia. Each percentage reduction in REM sleep was associated with approximately a 9% increase in the risk of incident dementia (hazard ratio 0.91; 95% confidence interval 0.86, 0.97). The magnitude of association between REM sleep percentage and dementia was similar following adjustments for multiple covariates including vascular risk factors, depressive symptoms, and medication use, following exclusions for persons with mild cognitive impairment at baseline and following exclusions for early converters to dementia. Stages of non-REM sleep were not associated with dementia risk.
Conclusions: Despite contemporary interest in slow-wave sleep and dementia pathology, our findings implicate REM sleep mechanisms as predictors of clinical dementia.
GLOSSARY
- Aβ=
- β-amyloid;
- AD=
- Alzheimer disease;
- AHI=
- apnea-hypopnea index;
- CI=
- confidence interval;
- DSM-IV=
- Diagnostic and Statistical Manual of Mental Disorders, 4th edition;
- FHS=
- Framingham Heart Study;
- HR=
- hazard ratio;
- MAOI=
- monoamine oxidase inhibitor;
- MCI=
- mild cognitive impairment;
- MMSE=
- Mini-Mental State Examination;
- PSG=
- polysomnography;
- SWS=
- slow-wave sleep
Footnotes
↵* These authors contributed equally to this work.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at Neurology.org
- Received February 14, 2017.
- Accepted in final form July 3, 2017.
- © 2017 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- Author response to Dr. Kim
- Matthew P. Pase, Senior Research Fellow, Swinburne University of Technologymatthewpase@gmail.com
- Jayandra J. Himali, Natalie A. Grima, Alexa S. Beiser, Claudia L. Satizabal, Hugo J. Aparicio, Robert J. Thomas, Daniel J. Gottlieb, Sanford H. Auerbach, Sudha Seshadri, Boston, MA
Submitted October 31, 2017 - Possible future study and other confounding factors in sleep architecture and link to dementia
- David D. Kim, MD, Western Universitydavid.kim@medportal.ca
Submitted October 11, 2017
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementiaAndrew J. Westwood, Alexa Beiser, Nikita Jain et al.Neurology, February 22, 2017 -
Article
Vitamin D and the risk of dementia and Alzheimer diseaseThomas J. Littlejohns, William E. Henley, Iain A. Lang et al.Neurology, August 06, 2014 -
Article
Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophyAndrew J. Westwood, Alexa Beiser, Charles DeCarli et al.Neurology, April 04, 2014 -
Article
Kidney Function, Kidney Function Decline, and the Risk of Dementia in Older AdultsA Registry-Based StudyHong Xu, Sara Garcia-Ptacek, Marco Trevisan et al.Neurology, May 05, 2021